FDA Panel Backs New Anti-Clotting Drug
3/20/2009
HealthDay - THURSDAY, March 19 (HealthDay News) -- The benefits of the
experimental blood-thinning drug rivaroxaban balance its risks, a U.S.
Food and Drug superintendence report panel said Thursday.
More: - Read the rest here
Share and enjoy
Post Comment
Entry 1 of 16100
Last Page | Next Page